|
Volumn 363, Issue 9402, 2004, Pages 82-
|
Erythropoietin to treat anaemia in patients with head and neck cancer.
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ERYTHROPOIETIN;
ANEMIA;
APOPTOSIS;
CELL DIVISION;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
DRUG EFFECT;
HEAD AND NECK TUMOR;
HUMAN;
NEOVASCULARIZATION (PATHOLOGY);
NOTE;
RANDOMIZED CONTROLLED TRIAL;
ANEMIA;
APOPTOSIS;
CELL DIVISION;
DISEASE-FREE SURVIVAL;
ERYTHROPOIETIN;
HEAD AND NECK NEOPLASMS;
HUMANS;
NEOVASCULARIZATION, PATHOLOGIC;
RANDOMIZED CONTROLLED TRIALS;
MLCS;
MLOWN;
|
EID: 1442356631
PISSN: None
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/s0140-6736(03)15189-6 Document Type: Note |
Times cited : (9)
|
References (0)
|